{"id":62440,"date":"2018-07-10T00:00:00","date_gmt":"2018-07-10T05:00:00","guid":{"rendered":"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/"},"modified":"2018-07-10T00:00:00","modified_gmt":"2018-07-10T05:00:00","slug":"internal-medicine-research-and-non-research-awards-second-quarter-2018","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/","title":{"rendered":"Internal Medicine Research and Non-Research Awards &#8211; Second Quarter 2018"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\"><p>From 04\/01\/2018 &#8211; 06\/30\/2018<\/p>\n<p><strong>Proposal Title, ID#, Sponsor, Dates, Direct Cost, Indirect Cost, Total Cost<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Chatzizisis, Ioannis S, <\/strong>Study of Access site for Enhancing PCI in STEMI for Seniors, 21288, Duke Clinical Research Institute, 04\/13\/18-04\/12\/20, $0, $2,940, $2,940<\/p>\n<p>Study of Access site for Enhancing PCI in STEMI for Seniors, 21288, Duke Clinical Research Institute, 04\/13\/18-04\/12\/20, $18,079, $981, $19,060<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Duan, Bin, <\/strong>3D Bioprinting of Biomimetic Constructs for Rotator Cuff Augmentation, 21244, DHHS\/NIH\/NIAMS, 06\/01\/18-05\/31\/19, $185,116, $97,186, $282,302<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Gumina, Richard J, <\/strong>Nucleotidases in atherothrombosis, 22083, American Heart Association &#8211; National, 01\/01\/18-06\/30\/18, $53,248, $5,325, $58,573<\/p>\n<p>RoboSep-5, 22021, NE. Bankers Assoc. Equipment Grants \/ U.N. Fdn, 04\/05\/18-04\/04\/19, $15,000, $0, $15,000<\/p>\n<p>Nucleotidases in atherothrombosis, 22083, American Heart Association &#8211; National, 07\/01\/18-06\/30\/19, $70,000, $7,000, $77,000<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Lowes, Brian D, <\/strong>PROVIDE-HF: Patient Reported Outcomes Investigation Following Initiation of Drug Therapy with Entresto (Sacubitril\/Valsartan) in Heart Failure No. Y8W00090, 22188, University of Kansas Medical Center Research Institute Inc, 01\/12\/18-12\/31\/19, $16,379, $8,435, $24,814<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Porter, Thomas Richard, <\/strong>&nbsp;Dodecafluoropentane Animal Expenses, 22061, NuvOx Pharma, LLC, 04\/01\/17-09\/30\/18, $120,840, $0, $120,840<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Windle, John Robert, <\/strong>PEW Healthcare Data Interoperability Project, 22144, Duke Clinical Research Institute, 04\/01\/18-09\/30\/18, $7,405, $649, $8,054<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Desouza, Cyrus Victor, <\/strong>Effect and safety of semaglutide 2.4 mg once- weekly in subjects with overweight or obesity who have reached target dose during run-in period, 21958, Novo Nordisk Pharmaceuticals, Inc., 05\/25\/18-05\/24\/20, $0 , $29,029, $29,029<\/p>\n<p>Effect and safety of semaglutide 2.4 mg once- weekly in subjects with overweight or obesity who have reached target dose during run-in period, 21958, Novo Nordisk Pharmaceuticals, Inc., 05\/25\/18-05\/24\/20, $149,868 , $9,677, $159,545<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Kharbanda, Kusum K, <\/strong>Impaired phospholipid methylation results in decreased lipid droplets lipolysis: role in hepatic steatosis, 21177, DHHS\/NIH\/NIAAA, 05\/05\/18-03\/31\/19, $249,661, $64,912, $314,573<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Ouellette, Michel M, <\/strong>RAC1 GTPase in tumorigenesis and progression of pancreatic cancer, 19286, DHHS\/NIH\/NCI, 05\/01\/18-04\/30\/19, $249,000, $125,745, $374,745<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Rasineni, Karuna, <\/strong>Pancreas-Adipose-Liver Axis: Role of Ghrelin and Insulin in Alcoholic Fatty Liver, 19221, DHHS\/NIH\/NIAAA, 05\/01\/18-04\/30\/19, $111,705, $8,936, $120,641<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Rochling, Fedja A, <\/strong>A 12-week, double-blind, randomized, placebo-controlled, Phase 2 study, to evaluate the effects of two doses of MBX-8025 in subjects with Primary Biliary Cirrhosis (PBC) and an inadequate response to ursodeoxycholic acid (UDCA), 19360, CymaBay Therapeutics, Inc., 03\/10\/16-03\/09\/17, $0 , ($12,582), ($12,582)<\/p>\n<p>A 12-week, double-blind, randomized, placebo-controlled, Phase 2 study, to evaluate the effects of two doses of MBX-8025 in subjects with Primary Biliary Cirrhosis (PBC) and an inadequate response to ursodeoxycholic acid (UDCA), 19360, CymaBay Therapeutics, Inc., 03\/10\/16-03\/09\/17, ($64,679), ($4,043), ($68,722)<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Kalil, Andre C, <\/strong>A Phase 2 Proof-of-Concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa &amp; A Phase 2 Randomized, Double-Blind, Placebo, Dose-Ranging&#8230;, 21527, Rhode Island Hospital, 03\/01\/18-04\/30\/19, $7,409, $1,926, $9,335<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Rupp, Mark E, <\/strong>An Open-label, Prospective, Observational Study of the Wear Time of an Investigational Antimicrobial Dressing containing CHG, 20174, 3M Company, 11\/09\/16-02\/08\/18, $0 , $1,081 , $1,081<\/p>\n<p>An Open-label, Prospective, Observational Study of the Wear Time of an Investigational Antimicrobial Dressing containing CHG, 20174, 3M Company, 11\/09\/16-02\/08\/18, $5,360 , $544 , $5,903<\/p>\n<p>NEBRASKA ANTIMICROBIAL STEWARDSHIP ASSESSMENT AND PROMOTION (NEBRASKA ASAP) SUBAWARD, 21053, NE DHHS, 08\/01\/17-07\/31\/18, $10,500, $0, $10,500<\/p>\n<p>Develop a Fully Autoclavable Respirator for the Biomedical Advanced Research and Development Authority (BARDA), 20994, Applied Research Associates, Inc., 12\/31\/17-12\/31\/18, $25,197, $588, $25,785<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Swindells, Susan, <\/strong>AIDS Drug Assistance Program [ADAP] Ryan White Title II Program (Part B), 21175, NE DHHS, 04\/01\/17-03\/31\/18, $1,429,627, $0, $1,429,627<\/p>\n<p>Title III:Categorical Grant Program to Provide Outpatient Early Intervention Services with Respect to HIV Disease (Ryan White Part C Outpatient EIS Program), 6247, DHHS\/HRSA, 01\/01\/18-12\/31\/18, $182,920 , $0 , $182,920<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Vanschooneveld, Trevor Craig, <\/strong>A Multi-center, Randomized, Double-blind Study to Compare the Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)., 17826, Actelion Pharmaceuticals US, Inc., 08\/04\/14-08\/03\/16, $0 , ($18,570), ($18,570) A Multi-center, Randomized, Double-blind Study to Compare the Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)., 17826, Actelion Pharmaceuticals US, Inc., 08\/04\/14-08\/03\/16, ($91,705), ($5,798), ($97,503)<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Ernani, Vinicius, <\/strong>Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab alone following Concurrent Chemoradiotherapy for Unresectable Stage IIIA\/IIIB Non-small Cell Lung Cancer (NSCLC), 21460, Big Ten Cancer Research Consortium, 03\/29\/18-03\/28\/19, $37,417, $9,468 , $46,885<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Lunning, Matthew A, <\/strong>A Phase 1 Dose-Ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects with Various Lymphomas and Leukemias, 21398, miRagen, 04\/14\/18-04\/13\/20, $0 , $20,315 , $20,315<\/p>\n<p>A Phase 1 Dose-Ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects with Various Lymphomas and Leukemias, 21398, miRagen, 04\/14\/18-04\/13\/20, $107,177, $6,771, $113,948<\/p>\n<p>Long-term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells, 21365, Celgene Corporation, 05\/04\/18-12\/31\/25, $0, $17,266, $17,266<\/p>\n<p>Long-term Follow-up Protocol for Subjects Treated with Gene-Modified T Cells, 21365, Celgene Corporation, 05\/04\/18-12\/31\/25, $91,544, $5,755, $97,299<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Bailey, Kristina Lynn, <\/strong>Mucociliary clearance in aging, 19544, DHHS\/NIH\/NIA, 06\/15\/18-04\/30\/19, $205,000, $103,525, $308,525<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Grant, Kathleen M, <\/strong>Probation and parole process evaluation, 22067, Nebraska Administrative Office of Probation, 04\/01\/18-09\/30\/19, $50,465, $5,046, $55,511<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Murphy, P. James James, <\/strong>A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics of PTI-808 in Healthy Subjects and in Adults with Cystic Fibrosis, 21870, Proteostasis Therapeutics, Inc., 05\/14\/18-05\/13\/20, $0, $10,870, $10,870<\/p>\n<p>A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics of PTI-808 in Healthy Subjects and in Adults with Cystic Fibrosis, 21870, Proteostasis Therapeutics, Inc., 05\/14\/18-05\/13\/20, $60,742, $3,623, $64,365<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Rennard, Stephen Israel,<\/strong> Defining the Role of Early Pulmonary Vascular Disease in COPD, 19225, University of Iowa, 04\/01\/18-03\/31\/19, $6,842, $3,523, $10,365<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Thompson, Austin Bassett,<\/strong> Multicenter, retrospective chart review of first-time Opsumit (macitentan) users in the United States, 21447, Actelion Pharmaceuticals Ltd., 04\/27\/18-04\/26\/20, $39,032 , $9,368 , $48,400<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Mikuls, Ted Richard, <\/strong>Investigations in Gout, Hyperuricemia, and Comorbidities(INSIGHT) Center of Research Translation (CORT), 20636, University of Alabama &#8211; Birmingham, 09\/20\/17-08\/31\/18, $32,698, $16,840 , $49,538<\/p>\n<p>Summer Undergraduate Alcohol Research Program, 19990, DHHS\/NIH\/NIAAA, 04\/01\/18-03\/31\/22, $53,535, $2,468, $56,003<\/p>\n<p>Driving Performance and Safety in Rheumatoid Arthritis, 21335, Rheumatology Research Foundation, 07\/01\/18-06\/30\/19, $185,185, $14,815, $200,000<\/p>\n<p>&nbsp;<\/p>\n<p><strong>O&#039;Dell, James Robert<\/strong>, Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat (STOP GOUT), 22174, University of Nebraska Foundation, 12\/01\/17-11\/30\/22, $56,285, $0, $56,285<\/p>\n<p>&nbsp;<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>From 04\/01\/2018 &#8211; 06\/30\/2018 Proposal Title, ID#, Sponsor, Dates, Direct Cost, Indirect Cost, Total Cost &nbsp; Chatzizisis, Ioannis S, Study of Access site for Enhancing PCI in STEMI for Seniors, 21288, Duke Clinical Research Institute, 04\/13\/18-04\/12\/20, $0, $2,940, $2,940 Study of Access site for Enhancing PCI in STEMI for Seniors, 21288, Duke Clinical Research Institute, [&hellip;]<\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-62440","post","type-post","status-publish","format-standard","hentry","category-uncategorized","department-internal-medicine-newsletter"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Internal Medicine Research and Non-Research Awards - Second Quarter 2018<\/title>\n<meta name=\"description\" content=\"From 04\/01\/2018 - 06\/30\/2018 Proposal Title, ID#, Sponsor, Dates, Direct Cost, Indirect Cost, Total Cost &nbsp; Chatzizisis, Ioannis S, Study of Access\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Internal Medicine Research and Non-Research Awards - Second Quarter 2018\" \/>\n<meta property=\"og:description\" content=\"From 04\/01\/2018 - 06\/30\/2018 Proposal Title, ID#, Sponsor, Dates, Direct Cost, Indirect Cost, Total Cost &nbsp; Chatzizisis, Ioannis S, Study of Access\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/\" \/>\n<meta property=\"og:site_name\" content=\"Newsroom\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/unmcedu\" \/>\n<meta property=\"article:published_time\" content=\"2018-07-10T05:00:00+00:00\" \/>\n<meta name=\"author\" content=\"Maria Daniels\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@unmc\" \/>\n<meta name=\"twitter:site\" content=\"@unmc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maria Daniels\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2018\\\/07\\\/10\\\/internal-medicine-research-and-non-research-awards-second-quarter-2018\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2018\\\/07\\\/10\\\/internal-medicine-research-and-non-research-awards-second-quarter-2018\\\/\"},\"author\":{\"name\":\"Maria Daniels\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#\\\/schema\\\/person\\\/64f8bde080ce4f3e8d0f0663db14e4bc\"},\"headline\":\"Internal Medicine Research and Non-Research Awards &#8211; Second Quarter 2018\",\"datePublished\":\"2018-07-10T05:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2018\\\/07\\\/10\\\/internal-medicine-research-and-non-research-awards-second-quarter-2018\\\/\"},\"wordCount\":873,\"publisher\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2018\\\/07\\\/10\\\/internal-medicine-research-and-non-research-awards-second-quarter-2018\\\/\",\"url\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2018\\\/07\\\/10\\\/internal-medicine-research-and-non-research-awards-second-quarter-2018\\\/\",\"name\":\"Internal Medicine Research and Non-Research Awards - Second Quarter 2018\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#website\"},\"datePublished\":\"2018-07-10T05:00:00+00:00\",\"description\":\"From 04\\\/01\\\/2018 - 06\\\/30\\\/2018 Proposal Title, ID#, Sponsor, Dates, Direct Cost, Indirect Cost, Total Cost &nbsp; Chatzizisis, Ioannis S, Study of Access\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2018\\\/07\\\/10\\\/internal-medicine-research-and-non-research-awards-second-quarter-2018\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2018\\\/07\\\/10\\\/internal-medicine-research-and-non-research-awards-second-quarter-2018\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/2018\\\/07\\\/10\\\/internal-medicine-research-and-non-research-awards-second-quarter-2018\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Internal Medicine Research and Non-Research Awards &#8211; Second Quarter 2018\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#website\",\"url\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/\",\"name\":\"Newsroom\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#organization\",\"name\":\"University of Nebraska Medical Center\",\"url\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/overview-1.png\",\"contentUrl\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/overview-1.png\",\"width\":500,\"height\":153,\"caption\":\"University of Nebraska Medical Center\"},\"image\":{\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/unmcedu\",\"https:\\\/\\\/x.com\\\/unmc\",\"https:\\\/\\\/instagram.com\\\/iamunmc\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/UNMCEDU\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/#\\\/schema\\\/person\\\/64f8bde080ce4f3e8d0f0663db14e4bc\",\"name\":\"Maria Daniels\",\"url\":\"https:\\\/\\\/www.unmc.edu\\\/newsroom\\\/author\\\/202cb962ac59075b964b07152d234b70\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Internal Medicine Research and Non-Research Awards - Second Quarter 2018","description":"From 04\/01\/2018 - 06\/30\/2018 Proposal Title, ID#, Sponsor, Dates, Direct Cost, Indirect Cost, Total Cost &nbsp; Chatzizisis, Ioannis S, Study of Access","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/","og_locale":"en_US","og_type":"article","og_title":"Internal Medicine Research and Non-Research Awards - Second Quarter 2018","og_description":"From 04\/01\/2018 - 06\/30\/2018 Proposal Title, ID#, Sponsor, Dates, Direct Cost, Indirect Cost, Total Cost &nbsp; Chatzizisis, Ioannis S, Study of Access","og_url":"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/","og_site_name":"Newsroom","article_publisher":"https:\/\/www.facebook.com\/unmcedu","article_published_time":"2018-07-10T05:00:00+00:00","author":"Maria Daniels","twitter_card":"summary_large_image","twitter_creator":"@unmc","twitter_site":"@unmc","twitter_misc":{"Written by":"Maria Daniels","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/#article","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/"},"author":{"name":"Maria Daniels","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/64f8bde080ce4f3e8d0f0663db14e4bc"},"headline":"Internal Medicine Research and Non-Research Awards &#8211; Second Quarter 2018","datePublished":"2018-07-10T05:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/"},"wordCount":873,"publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/","url":"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/","name":"Internal Medicine Research and Non-Research Awards - Second Quarter 2018","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#website"},"datePublished":"2018-07-10T05:00:00+00:00","description":"From 04\/01\/2018 - 06\/30\/2018 Proposal Title, ID#, Sponsor, Dates, Direct Cost, Indirect Cost, Total Cost &nbsp; Chatzizisis, Ioannis S, Study of Access","breadcrumb":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.unmc.edu\/newsroom\/2018\/07\/10\/internal-medicine-research-and-non-research-awards-second-quarter-2018\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.unmc.edu\/newsroom\/"},{"@type":"ListItem","position":2,"name":"Internal Medicine Research and Non-Research Awards &#8211; Second Quarter 2018"}]},{"@type":"WebSite","@id":"https:\/\/www.unmc.edu\/newsroom\/#website","url":"https:\/\/www.unmc.edu\/newsroom\/","name":"Newsroom","description":"","publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.unmc.edu\/newsroom\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.unmc.edu\/newsroom\/#organization","name":"University of Nebraska Medical Center","url":"https:\/\/www.unmc.edu\/newsroom\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/","url":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","contentUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","width":500,"height":153,"caption":"University of Nebraska Medical Center"},"image":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/unmcedu","https:\/\/x.com\/unmc","https:\/\/instagram.com\/iamunmc","https:\/\/www.youtube.com\/user\/UNMCEDU"]},{"@type":"Person","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/64f8bde080ce4f3e8d0f0663db14e4bc","name":"Maria Daniels","url":"https:\/\/www.unmc.edu\/newsroom\/author\/202cb962ac59075b964b07152d234b70\/"}]}},"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/62440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/comments?post=62440"}],"version-history":[{"count":0,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/62440\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/media?parent=62440"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/categories?post=62440"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/tags?post=62440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}